Overall, scientific vacancies in the pharmaceutical industry across the EU (including the UK) rose 21.8% from 2016 to 2017, showing encouraging signs for the industry.
However while vacancies for scientific roles in the EU overall have risen year on year since 2016, intriguingly they have dropped proportionately in the UK, dropping to 31.2% in 2017, and to 29.3% in 2018 so far.
In comparison to the UK, the Netherlands has shown a steady increase in scientific vacancies between 2016 and for 2017, rising by 33% making it one of the fastest growing regions.
– Scientific vacancies in the sector were up 9.9% year on year.
– Overall, over 72% of all posted vacancies were located in South East, East and London regions, with Oxford had the fastest growth across the combined regions.
– R&D is now the single largest area of scientific hiring, with volumes up 19.6 year on year.
– The last quarter of 2017 saw a record level of activity when analysing the last three years.
– R&D specifically has continued to be the single largest area of hiring.
– Astrazeneca dominate, with more than double the vacancies compared to the second largest employer.
Medical Affairs has been a significant growth area over the past two years, with a 10% increase during this time period.
By sector, roles within biotechnology have been growing faster than others. By role, medical writing is the fastest, up 70% in two years. By country, Italy has witnessed the biggest increase, up 278% between 2015 and 2017.
In terms of the headline findings,
Immunology, pharmacology and immune diseases seem to be the main focuses of R&D hiring.
Germany has now overtaken the UK in terms of the number of R&D vacancies published overall. What is happening in Germany to prompt this change?
Across Europe, Merck is now the leading employer in terms of number of R&D vacancies over the past twelve months.